Fundraising Fox

KaloCyte

Baltimore, US · Founded 2016 · Missouri corporation · 5 known investors

kalocyte.com ↗

KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply. The pre-clinical stage biotech company is supported by federal grants and investor funding.

BiotechDeep TechHealthtechMedical Devicesin /kalocyte-inc

Founders & leadership

ADAllan Doctor
Allan DoctorinCo-Founder & CSO
DPDipanjan Pan
Dipanjan PaninCo-Founder, Chief Technical Officer
PSPhilip Spinella
Philip SpinellainCo-Founder, Chief Medical Officer
DG
Daniel GetmanDirector
GL
Gregory LanzaDirector

Investors · 5

BioAdvanceConshohocken · $500K – $1.5M
BioGenerator VenturesSt. Louis · $50K – $250K
Maryland TEDCOUpper Marlboro · $500K – $1.5M
NYBC VenturesNew York
Old Line Capital PartnersBowie

Reported raises · per SEC filings

Form D private placements
▶$800KraisedMay 2018 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dipanjan PanDirector
  • Daniel GetmanDirector
  • Allan DoctorExecutive Officer, Director
  • Gregory LanzaDirector
  • Philip SpinellaDirector
Offering amount
$800K
Amount sold
$800K
Minimum investment
$10K
First sale
Apr 2018
Incorporated
Corporation, Missouri, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.